Latest Intelligence in South and Central America

Published within

« | ... | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ... | » »|

Type Product title / description Pub Price
ResearchWire
ResearchWire

Chips: top flavors in new products

Published By Datamonitor
10 Mar 2006
ResearchWire
ResearchWire

Toilet cleaners: top fragrances in new launches

Published By Datamonitor
13 Mar 2006
ResearchWire
ResearchWire

New household goods launches Nov-Jan: growth from fresh air

Published By Datamonitor
13 Mar 2006
ResearchWire
ResearchWire

Product claims: new household goods launches, Nov-Jan

Published By Datamonitor
13 Mar 2006
Expert View
Expert View

Drug reps must embrace technology to avoid missing sales opportunities

In a pharmaceutical market where the days of the primary care blockbuster-selling drug appear numbered, the days of pharma sales representatives having time to visit physicians with drug samples are also waning. Reps must now embrace internet technology to ensure samples are efficiently distributed to physicians and also take on the role of educators in their dynamic relationships with physicians.

Published By Datamonitor
15 Mar 2006
Expert View
Expert View

Europcar's new owner shifts up a gear

The acquisition of Europcar has cost the French private equity firm Eurazeo more than many had predicted, and with good reason. Following a few years of damaging declines, the outlook is now bright for the global car rental market, and Europcar's strategy of expansion into North America and China is one many private equity firms would bet their money on. Jugoslav Stojanov reports...

Published By Datamonitor
16 Mar 2006
ResearchWire
ResearchWire

Vaccines: sales show global growth

Published By Datamonitor
17 Mar 2006
ResearchWire
ResearchWire

Pulmonary arterial hypertension: market on the pulse of global growth

Published By Datamonitor
17 Mar 2006
ResearchWire
ResearchWire

Antihypertensives: ARBs at the heart of the market

Published By Datamonitor
27 Mar 2006
CommentWire
CommentWire

Omega-3: oil elixir takes a tumble

New research has cast doubts over the health benefits offered by the consumption of omega-3. Given that consumers are naturally wary of manufacturers' health claims, it is likely that sales of both oily fish, which contains high levels of the fatty acids, and omega-3 supplements will suffer in the short term.

Published By Datamonitor
27 Mar 2006

« | ... | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ... | » »|

No help is available.